Commentary · 24 Feb 2026
Conference abstractPublished 1 Dec 2016
LPS effect on specific interleukin (IL) mRNA expression in the spleen and brain
VA Puget Sound Health Care System, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Neuroinflammation is proposed to be an important component in the development of several central nervous system (CNS) disorders including depression, AlzheimerâÂ?Â?s disease (AD), ParkinsonâÂ?Â?s disease (PD), and traumatic brain injury (TBI). The intra-peritoneal (i.p.) administration of lipopolysaccharide (LPS) induces peripheral inflammation and neuroinflammation as evident be elevations in blood and brain levels of cytokines. However, the cellular and anatomical sources of these cytokines are not known. Here, we used in situ hybridization to examine in brain and spleen the sources of cytokine production after 3-injection regime previously shown to elevate cytokine levels in brain and blood. Administration of LPS significantly increased mRNA expression of interleukin (IL)-6 and -10 in the spleen, an important organ for an immune response, consistent with increases in blood levels for these cytokines after LPS. LPS significantly decreased IL-6 receptor (-6R) mRNA in the spleen, but had no effect on IL-7 or IL-7R mRNA. In the CNS, IL-6 mRNA was expressed in neurons prior to LPS in regions that include the cortex, cerebellum and hippocampus. After LPS, IL-6 mRNA expression in these neuronal populations was unchanged, but a diffuse non-neuronal pattern appeared throughout the brain. IL-6R mRNA showed a pattern of expression similar to IL-6 mRNA and LPS significantly elevated all regions, except cerebellum, mainly in animals which expressed the non-neuronal IL-6 mRNA after LPS. IL-10 mRNA was widely expressed in neurons in many discrete brain regions, with LPS tending to decrease expression in forebrain regions and increase it in hindbrain regions. IL-7 and IL-7R had limited expression mainly to the cerebellum. LPS had no effect on IL-7 or IL-7R mRNA in the CNS. These studies indicate that LPS induced neuroinflammation has unique effects on regional and cellular patterns in the CNBS and splenic cytokine expression. It is apparent that LPS can affect neuronal and non-neuronal cells in the brain, with IL-6 demonstrating the greatest change. Recent Publications 1. Szot P, Franklin A, Miguelez C, Wang Y, Vidaurrazaga I, Ugedo L, Sikkema C, Wilkinson C W, Raskind M A (2016) Depressive-like behavior observed with a minimal loss of locus coeruleus (LC) neurons following administration of 6-hydroxydopamine is associated with electrophysiological changes and reversed with precursors of norepinephrine. Neuropharmacology 101:76-86. 2. Szot P (2012) Common factors between AlzheimerâÂ?Â?s disease, ParkinsonâÂ?Â?s disease and epilepsy: Possible role of the noradrenergic nervous system. Epilepsia 53(1):61-66, 2012. 3. McMillan P J, White S S, Franklin A, Greenup J L, Leverenz J B, Raskind M A, Szot P (2011) Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in ParkinsonâÂ?Â?s disease and AlzheimerâÂ?Â?s disease. Brain Res 1373:240-252. 4. Szot P, White S S, Greenup J L, Leverenz J B, E R Peskind, Raskind M A (2006) Compensatory changes in the noradrenergic nervous system in the locus coeruleus and hippocampus of postmortem subjects with AlzheimerâÂ?Â?s disease and dementia with Lewy bodies. J Neurosci. 26(2):467-478.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Neurological Disorders.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalNeurological Disorders
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Patricia Szot”

